RESEARCH LINES
- Generation of therapeutic antibodies sensible to stimulus
- Directed evolution of peptides and proteins using phage display
- Development of antibody-drug conjugates for the treatment of brain tumours
MEMBER OF:
School of Engineering
Materials Engineering
Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.
LATEST PROJECTS
ADC2GBM (Development of brain-permeable masked nanobody-drug conjugates to eliminate glioma stem cells)
Innovative formulation to treat glioma using brain-permeable masked nanobody-drug conjugates.
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
LINKED NEWS
Interview
Producing masked antibodies through targeted evolution
01/09/2022
“In the ADC2GBM project, we're combining our experience in targeted evolution and antibody engineering to develop activatable antibody-drug conjugates for the treatment of glioblastoma multiforme”
READ FULL NEW
7 Questions for...
Cristina Díaz
12/05/2022
Interview to Dr Cristina Díaz, researcher with the GEMAT group at the IQS School of Engineering.
READ FULL NEW
